SCHEMBL21038093

SCHEMBL21038093

ICC/C=C/c1ccc2ccccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.54
RAB9A P51151 8/20 0.54
LMNA P02545 7/20 0.54
NPC1 O15118 7/20 0.54
PKM P14618 3/20 0.54
CYSLTR2 Q9NS75 1/20 0.49
CYSLTR1 Q9Y271 1/20 0.49
MAPT P10636 7/20 0.49
SMN1; SMN2 Q16637 5/20 0.49
L3MBTL1 Q9Y468 4/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
TDP1 Q9NUW8 3/20 0.49
ECE2 P0DPD6 2/20 0.49
HTT P42858 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C19 P33261 1/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28443608 0.79 RAB9A (0.80) KDM4ERAB9ALMNANPC1PKM
SCHEMBL22501441 0.79 KDM4E (0.50) KDM4ERAB9ALMNANPC1PKM
SCHEMBL5099480 0.79 KDM4E (0.58) KDM4ERAB9ALMNANPC1PKM
SCHEMBL5093237 0.79 KDM4E (0.58) KDM4ERAB9ALMNANPC1PKM
SCHEMBL5093246 0.79 KDM4E (0.58) KDM4ERAB9ALMNANPC1PKM
SCHEMBL372181 0.79 KDM4E (0.58) KDM4ERAB9ALMNANPC1PKM
SCHEMBL9297594 0.78 LMNA (0.53) KDM4ERAB9ALMNANPC1PKM
SCHEMBL18050160 0.78 KDM4E (0.49) KDM4ERAB9ALMNANPC1PKM
SCHEMBL18050167 0.78 KDM4E (0.49) KDM4ERAB9ALMNANPC1PKM
SCHEMBL5412134 0.77 RAB9A (0.66) KDM4ERAB9ALMNANPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301330-B2 N, C-chelate four-coordinate organoborons with full colourtunability COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2019-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10301330-B2 N, C-chelate four-coordinate organoborons with full colourtunability CNOT7, CDYL, CRY1 KDM4E 1459/4885RAB9A 1063/4885LMNA 1952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.